Suberoylanilide hydroxamic acid overcomes erlotinib-acquired resistance via phosphatase and tensin homolog deleted on chromosome 10-mediated apoptosis in non-small cell lung cancer

MLA

Peng-Fei Wu, et al. “Suberoylanilide Hydroxamic Acid Overcomes Erlotinib-Acquired Resistance via Phosphatase and Tensin Homolog Deleted on Chromosome 10-Mediated Apoptosis in Non-Small Cell Lung Cancer.” Chinese Medical Journal, vol. 133, May 2020, pp. 1304–11. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....24dd4e87601ccdd169251827e5696863&authtype=sso&custid=ns315887.

APA

Peng-Fei Wu, Wei-Wei Gao, Cui-Lan Sun, Tai Ma, Ji-Qing Hao, & Xiu-Yuan Hao. (2020). Suberoylanilide hydroxamic acid overcomes erlotinib-acquired resistance via phosphatase and tensin homolog deleted on chromosome 10-mediated apoptosis in non-small cell lung cancer. Chinese Medical Journal, 133, 1304–1311.

Chicago

Peng-Fei Wu, Wei-Wei Gao, Cui-Lan Sun, Tai Ma, Ji-Qing Hao, and Xiu-Yuan Hao. 2020. “Suberoylanilide Hydroxamic Acid Overcomes Erlotinib-Acquired Resistance via Phosphatase and Tensin Homolog Deleted on Chromosome 10-Mediated Apoptosis in Non-Small Cell Lung Cancer.” Chinese Medical Journal 133 (May): 1304–11. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....24dd4e87601ccdd169251827e5696863&authtype=sso&custid=ns315887.